 neoadjuv cisplatin vinblastin chemotherapi advanc non-smal cell lung cancer twenty-eight patient unresect non-smal cell lung cancer nsclc neoadjuv chemotherapi cisplatin day vinblastin week complet induct chemotherapi patient resect patient resect underw thoracotomi patient thorac radiat therapi cgi addit chemotherapi patient neoadjuv treatment partial respons neoadjuv chemotherapi overal respons rate confid interv patient suffici tumor regress cur resect complet resect patient overal median surviv month rang month surviv rate primari toxic neoadjuv chemotherapi moder eastern cooper oncolog group grade nausea emesi patient hematolog toxic modest patient grade leukopenia fever neutropenia uncommon septic episod treatment-rel death histor control radiat therapi cisplatin-bas neoadjuv chemotherapi median long-term surviv stage iii nsclc patient